Navigation Links
World Renowned Scientist, Dr. Rongxiang Xu Speaks Out About Nobel Assembly Statement Claiming They Have Not Heard Of Him
Date:12/11/2012

LOS ANGELES, Dec. 11, 2012 /PRNewswire/ -- Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life scientist and medical scientist, addresses The Nobel Assembly at Karolinska Institutet's initial statement regarding his lawsuit filing last week against the Academy citing Libel and unfair competition.

The Assembly provided a statement on their site: http://www.nobelprizemedicine.org/?p=3226 whereby they implied they have not heard of Dr. Xu, the founder of "human body regenerative restoration science" and a renowned life scientist and medical scientist. The Nobel Assembly's lack of acknowledgment is difficult to fathom considering the fact that Dr. Xu has a lifetime achievement in in situ regeneration research and is known worldwide as a pioneer in the field of regenerative medicine.

Furthermore, Dr. Xu was interviewed exclusively in 2003 by Sweden's Ministry of Education and Science and Sweden's national television SVT covering the topic of human body regeneration science.  It is also unlikely that The Nobel Assembly did not check US patents before they published statements on the Nobel Prize Awards.

Dr. Xu states, "I am not interested in who is awarded the Nobel Prize and I do not devalue the award.  I am concerned about the statements made by the Nobel Assembly.  I seek clarification regarding the issue of 'pluripotency by reprogramming' as it has been incorrectly stated and this can impact the safety of human life. I hope the Nobel Assembly can clarify what its 'pluripotency' means, is it completely conforming with the nature of human life? Or, is it the pluripotency of human cancer cells."

The Plaintiff, Dr. Xu is represented by the Ardent Law Group in California (case number 30-2012-00615804). For additional information, please contact Jane Westgate 336.608.4439, or Cheryl Riley 703.683.1798.


'/>"/>
SOURCE mebo-international.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Ansell y Comasec presentan Shared World of Innovation en ExpoProtection 2012
2. DOW Chemical at the World Drug Delivery & Formulation Summit 2013
3. Separation Design Group Launches Crowd-Funding Campaign for Worlds Smallest Oxygen Machine
4. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
5. SurgiQuest, Inc. Secures Additional $18.5 Million Funding to Fuel Worldwide Expansion and Commercialization Efforts
6. Ansell and Comasec Unveil Shared World of Innovation at ExpoProtection 2012
7. Premier Healthcare Alliance Awards 3-Year Group Purchasing Contract for Diaper and Adult Brief Waste Receptacles to Sinclair Worldwide
8. U.S. News & World Report and Pharmacy Times Introduce New Pharmacist-recommended Health Product Website
9. AVAC Report Finds That World is Already Falling Behind Pace to End AIDS Epidemic; Five Essential Actions Needed in 2013 to Avoid Historic Missed Opportunity
10. Philips transforms care to address the economic challenges faced by radiology departments and radiologists worldwide
11. Easy on the Stomach: ALCAT Worldwide Sponsors Successful Conference on Gut, Brain & Autoimmune Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... , Feb. 21, 2017 Medical Oxygen ... report: http://www.reportlinker.com/p04711311-summary/view-report.html Medical oxygen concentrators ... other respiratory diseases. Patients having low level of ... oxygen concentrators. Oxygen concentrators are to be used ... the counter. Medical oxygen concentrators work either on ...
(Date:2/21/2017)... , Feb. 21, 2017   BeyondSpring Pharmaceuticals ... the development of innovative immuno-oncology cancer therapies, today ... data from its Phase 2 trial of BeyondSpring,s ... treatment of non-small cell lung cancer (NSCLC) with ... this year,s ASCO-SITC Clinical Immuno-Oncology Symposium in ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... Alto-Shaam is pleased to ... Multi-Cook Oven offers up to four ovens in one. Control temperature, fan speed ... unmatched evenness in cooking. Alto-Shaam has partnered with Appliance Innovation to introduce this ...
(Date:2/22/2017)... FRANCISCO BAY AREA - NORTHERN CALIFORNIA (PRWEB) , ... ... ... (PMF) aims to expand the pipeline and the number of African American/Black ... that encourages medical students and residents to pursue their careers as physicians in ...
(Date:2/21/2017)... ... February 21, 2017 , ... Robins & Morton ... Durant, Oklahoma, on Feb. 21. , The celebration began with a ribbon cutting ... employees, the construction team and tribal leadership. , Choctaw Nation Durant Regional ...
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... ... announce that Marc Philpart, senior director at PolicyLink, will be the keynote speaker ... about the Boys and Men of Color Framework, which develops comprehensive strategies to ...
(Date:2/21/2017)... ... 21, 2017 , ... As recently as 2015, rhinoplasty was one of the ... Plastic Surgeons. Some patients want to make a change in the appearance of their ... breathing ability. The team at usrhinoplasty.org is expanding its article database to ...
Breaking Medicine News(10 mins):